NCT07843498: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- State
- Under way
- Phase
- Phase 3
- People
- 3,900 planned
- Started
- 30 Sep 2026
- Primary completion
- 21 Dec 2028
- Arms
- Petrelintide
- Results
- None posted
- 28 Sep 2026: Trial registered
- 30 Sep 2026: Trial started